Trivedon (Trimetazidine) is used for symptomatic treatment of stable angina (chest pain) as an additional therapy to other frontline medicines. Trimetazidine belongs to the metabolic modulators class of medicines also known as pFOX inhibitors (partial fatty-acid-oxidation inhibitors). In the myocardium (muscles of the heart), trimetazidine partially inhibits the metabolic process (?-oxidation) of fatty acid that requires more oxygen consumption) by blocking a specific enzyme (long-chain 3-ketoacyl-CoA thiolase) and thereby triggering glucose oxidation that requires less oxygen consumption.